Company Description
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.
The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Country | United States |
IPO Date | Jul 28, 2016 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 992 |
CEO | Sheri Louise Dodd |
Contact Details
Address: 3701 Wayzata Boulevard Minneapolis, Minnesota United States | |
Website | https://www.tactilemedical.com |
Stock Details
Ticker Symbol | TCMD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001027838 |
CUSIP Number | 87357P100 |
ISIN Number | US87357P1003 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Sheri Louise Dodd | Chief Executive Officer & Director |
Elaine M. Birkemeyer | Chief Financial Officer |
John David Kaercher | Chief Information Officer |
Daniel L. Reuvers | Director & Advisor |
Dr. Antonios P. Gasparis F.A.C.S., M.D. | Chief Medical Officer & Member of Vascular Strategic Advisory Board |
Janelle M. Strop | Chief Human Resource Officer |
Jerry A. Sauber | Senior Vice President of Manufacturing, Operations, R&D |
Kristie T. Burns | Senior Vice President of Marketing & Clinical Affairs |
Sherri Ferstler | Senior Vice President of Sales |
Sunday J. Hoy Esq. | Vice President of Regulatory Affairs & Chief Compliance Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 04, 2024 | 10-Q | Quarterly Report |
Nov 04, 2024 | 8-K | Current Report |
Aug 14, 2024 | 4 | Filing |
Aug 09, 2024 | 4 | Filing |
Aug 05, 2024 | 10-Q | Quarterly Report |
Aug 05, 2024 | 8-K | Current Report |
Jul 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |